Diana Lim - Department of Pathology, National University Hospital

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 125 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Unveiling the Unique Identity of Clear-Cell Endometrial Cancer (CCEC): A Comprehensive Comparative Analysis with Ovarian Counterpart and Other Endometrial Subtypes

Felix Blanc-Durand,Natalie Ngoi,Etienne Rouleau,Patricia Pautier,Judith Michels,Kaissa Ouali,Catherine Genestie,Yi Wan Lim,Diana Lim,Silvana Talisa Wijaya,Alexandra Leary,David Shao Peng Tan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Comprehensive Characterization of Genomic Features and Clinical Outcomes Following Targeted Therapy and Secondary Cytoreductive Surgery in OCCC: a Single Center Experience

Silvana Talisa Wijaya,Natalie Yl Ngoi,Jerold Wz Loh,Tuan Zea Tan,Diana Lim, Irfan Sagir Khan,Yee Liang Thian, Alexa Lai,Bertrand Wl Ang,Pearl Tong,Joseph Ng, Jeffrey Jh Low,Arunachalam Ilancheran,Siew Eng Lim,Yi Wan Lim,David Sp Tan

Journal of gynecologic oncologyno. 5 (2024): e69-e69

引用0浏览0WOS引用

531 Loss-of-heterozygosity As a Biomarker for Genomic Instability and Poor Outcomes in Endometrial Cancer

Felix Blanc-Durand,Damien Vasseur,Patricia Pautier,Judith Michels,Etienne Rouleau,Yi Wan Lim,Siew Eng Lim,Diana Lim,Silvana Wijaya, Manavi Sachdeva,Natalie Ngoi,Benjamin Besse,Alexandra Leary,David Sp Tan

Poster and E-Posters (2024)

引用0浏览0引用

Loss-of-Heterozygosity As a Biomarker of Genomic Instability in Endometrial Cancer

Felix Blanc-Durand,Etienne Rouleau,Damien Vasseur,Patricia Pautier,Judith Michels,Kaissa Ouali,Silvana Wijaya, Manavi Sachdeva,Diana Lim,Natalie Ngoi,Yi Wan Lim,Siew Eng Lim, Alexandra Leary,David Sp Tan

crossref（2024）

引用0浏览0引用

774P CCNE1 Amplification Defines a Good Prognostic Subgroup among BRCAwt/HRDneg Advanced High-Grade Ovarian Cancer (HGOC)

F. Blanc-Durand,N.Y.L. Ngoi,E. Rouleau, S.Y.R. Ang,P. Pautier,J. Michels,K. Ouali,C. Genestie,S. Cotteret,Y.W. Lim,S.E. Lim,D. Lim,S.T. Wijaya, A.C. Seong,A. Leary,D.S. Tan

Annals of Oncology (2023): S524-S525

引用0浏览0引用

LBA8 Preliminary Efficacy of Pembrolizumab Plus Lenvatinib (PL) in Recurrent Clear Cell Gynecological Cancer (CCGC): Phase II LARA Trial (GCGS-OV4/ APGOT-OV3)

N. Y. Ngoi,J-Y. Lee,Y. W. Lim,D. Lim,Y. L. Thian,A. Gopinathan,S. E. Lim,J. Low, J. Ng, P. Tong, J. Zhu,B. C. Tai,Y. J. Lee, J. Park, J-W. Kim,B-G. Kim,D. S. Tan

Annals of oncology (2023): S1584-S1584

引用0浏览0引用

A Study into Micro-RNA Expression in Endometrial Carcinomas in an Asian Population

Gideon Tan,Susan Swee-Shan Hue, Elsie Cheruba, Yu Jin,Ling-Wen Ding,Sai Mun Leong,He Cheng,Diana Lim

LABORATORY INVESTIGATIONno. 3 (2023): S987-S988

引用0浏览0引用

Corrigendum to “chemotherapy Response Score (CRS) As a Surrogate Marker for Homologous Recombination Deficiency (HRD) Based on Loss of Heterozygosity (LOH) in High Grade Serous Ovarian Cancer (HGSOC) (165)” [gynecologic Oncology Volume 166, Supplement 1, August 2022, Page S98]

Silvana Talisa Wijaya, Joshua P. Loh,Diana Lim,Soon Boon Justin Wong, Jonathan Sze Choong Low,Joseph Kee‐Yin Ng,Pearl Tong,A. Ilancheran,Yi Wan Lim,Siew Eng Lim,Natalie Y.L. Ngoi,David S.P. Tan

Gynecologic oncology (2023): 333-333

引用0浏览0引用

Clinical Relevance of Telomerase Upregulation Via TERT Promoter Mutation or TERC Amplification in High-Grade Ovarian Cancer

Felix Blanc-Durand,Natalie Ngoi,Damien Vasseur,Patricia Pautier,Judith Michels,Kaissa Ouali,Catherine Genestie,Sophie Cotteret, Etenne Rouleau,Yi Wan Lim,Siew Eng Lim,Diana Lim,Silvana Talisa Wijaya,Alexandra Leary,David S. P. Tan

MOLECULAR CANCER THERAPEUTICSno. 12 (2023)

引用0浏览0引用

Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition

Vignesh Sundararajan,Tuan Zea Tan,Diana Lim,Yanfen Peng,Antje Margret Wengner,Natalie Yan Li Ngoi,Anand D Jeyasekharan,David Shao Peng Tan

J Pathol（2023）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn